From the IPO:
The Company intends to commercialise its diabetic kidney IP by engaging a licensing partner within the next 12 months.
It floated in April 2015 then they got until April 2016 to meet said objective (although the sooner the better!)
Preliminary Final Report 31st August
"The Company is engaged in positive, ongoing discussions with major pharmaceutical companies in relation to partnering and licensing opportunities for PromarkerD, and it will provide details on the progress of these discussions in due course."
From the AGM presentation 20 November
"Pending deal flow amidst fast-growing international activity"
From the IPO: The Company intends to commercialise its diabetic...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.42M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $187.1K | 634.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 81754 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 15.57pm 27/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |